- Home
- VIST vs ARWR Comparison
VIST vs ARWR Comparison
Compare VIST & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIST
- ARWR
- Stock Information
- Founded
- VIST 2017
- ARWR 2003
- Country
- VIST Mexico
- ARWR United States
- Employees
- VIST N/A
- ARWR N/A
- Industry
- VIST Oil & Gas Production
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- VIST Energy
- ARWR Health Care
- Exchange
- VIST Nasdaq
- ARWR Nasdaq
- Market Cap
- VIST 5.1B
- ARWR 5.9B
- IPO Year
- VIST 2019
- ARWR 1993
- Fundamental
- Price
- VIST $48.21
- ARWR $39.23
- Analyst Decision
- VIST Buy
- ARWR Strong Buy
- Analyst Count
- VIST 3
- ARWR 8
- Target Price
- VIST $57.67
- ARWR $47.75
- AVG Volume (30 Days)
- VIST 1.7M
- ARWR 1.7M
- Earning Date
- VIST 10-22-2025
- ARWR 11-25-2025
- Dividend Yield
- VIST N/A
- ARWR N/A
- EPS Growth
- VIST 30.45
- ARWR N/A
- EPS
- VIST 6.75
- ARWR N/A
- Revenue
- VIST $2,226,451,000.00
- ARWR $572,976,000.00
- Revenue This Year
- VIST $42.62
- ARWR $21,287.22
- Revenue Next Year
- VIST $22.85
- ARWR N/A
- P/E Ratio
- VIST $6.97
- ARWR N/A
- Revenue Growth
- VIST 49.86
- ARWR 2816.20
- 52 Week Low
- VIST $31.63
- ARWR $9.57
- 52 Week High
- VIST $61.67
- ARWR $43.69
- Technical
- Relative Strength Index (RSI)
- VIST 71.13
- ARWR 54.82
- Support Level
- VIST $46.69
- ARWR $37.56
- Resistance Level
- VIST $49.82
- ARWR $40.94
- Average True Range (ATR)
- VIST 2.10
- ARWR 2.11
- MACD
- VIST 0.65
- ARWR -0.38
- Stochastic Oscillator
- VIST 84.05
- ARWR 32.32
About VIST Vista Energy S.A.B. de C.V. each representing one series A share with no par value
Vista Energy SAB de CV is an independent oil and gas company. It is focused on shale oil and shale gas exploration at its main assets in Vaca Muerta. The company has operations in Argentina and Mexico. The company operates in a single segment- the exploration and production of Crude oil, Natural gas, and LPG. Geographically, It operates in Argentina and Mexico. it generates the majority of its revenue from Argentina.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.